Variability of Skin Pharmacokinetic Data: Insights from a Topical Bioequivalence Study Using Dermal Open Flow Microperfusion.

Variability of Skin Pharmacokinetic Data: Insights from a Topical Bioequivalence Study Using Dermal Open Flow Microperfusion.
复制标题

DOI:
10.1007/s11095-020-02920-x
复制
发表时间:
2020-09-28
影响因子:
3.7
通讯作者:
Sinner F
Sinner F
中科院分区:
医学3区
文献类型:
--
作者:
Bodenlenz M;Augustin T;Birngruber T;Tiffner KI;Boulgaropoulos B;Schwingenschuh S;Raney SG;Rantou E;Sinner F

文献摘要

参考文献

被引文献

相似文献

皮肤开放流微灌注(dOFM)先前已证明其在临床研究中用于评估局部药物产品的生物等效性(BE)。我们的目的是表征该研究中皮肤药代动力学数据的变异性来源。利用来自20名健康成人的临床dOFM研究的多变量数据进行探索性统计分析,该研究评价了奥地利试验(T)和美国参考(R)阿昔洛韦乳膏(5%产品)的BE或缺乏BE。logAUC值的总体变异性(CV:R为39%,T为45%)主要由受试者间变异性(R:82%,T:91%)决定,受试者间变异性与受试者的皮肤电导最相关。受试者内变异性占总体变异性的18%(R)和9%(T);皮肤治疗部位或方法学因素对该变异性无显著影响。受试者间变异性是阿昔洛韦总体变异性的主要组成部分,治疗部位位置对受试者内变异性没有显著影响。这些结果支持在同一受试者中同时评估T和R产品的dOFM BE研究设计,其中T和R治疗部位不一定需要彼此相邻。皮肤微观结构的局部变化可能是受试者内变异的主要原因。
Dermal open flow microperfusion (dOFM) has previously demonstrated its utility to assess the bioequivalence (BE) of topical drug products in a clinical study. We aimed to characterize the sources of variability in the dermal pharmacokinetic data from that study. Exploratory statistical analyses were performed with multivariate data from a clinical dOFM-study in 20 healthy adults evaluating the BE, or lack thereof, of Austrian test (T) and U.S. reference (R) acyclovir cream, 5% products. The overall variability of logAUC values (CV: 39% for R and 45% for T) was dominated by inter-subject variability (R: 82%, T: 91%) which correlated best with the subject’s skin conductance. Intra-subject variability was 18% (R) and 9% (T) of the overall variability; skin treatment sites or methodological factors did not significantly contribute to that variability. Inter-subject variability was the major component of overall variability for acyclovir, and treatment site location did not significantly influence intra-subject variability. These results support a dOFM BE study design with T and R products assessed simultaneously on the same subject, where T and R treatment sites do not necessarily need to be next to each other. Localized variation in skin microstructure may be primarily responsible for intra-subject variability.
DOI: 10.1038/sj.jid.5700495
发表时间: 2007-01-01
影响因子: 6.5
作者:
Benfeldt, Eva;Hansen, Steen H.;Shah, Vinod P.
通讯作者: Shah, Vinod P.
DOI: 10.1016/j.ejps.2003.11.004
发表时间: 2004-02-01
影响因子: 4.6
作者:
Simonsen, L;Jorgensen, A;Groth, L
通讯作者: Groth, L
DOI: 10.1016/j.ijpharm.2005.07.005
发表时间: 2005-10-13
影响因子: 5.8
作者:
Khan, GM;Frum, Y;Meidan, VM
通讯作者: Meidan, VM
DOI: 10.1016/j.ejpb.2009.12.003
发表时间: 2010-03-01
影响因子: 4.9
作者:
Meidan, Victor M.;Pritchard, David
通讯作者: Pritchard, David
DOI: 10.1080/1061186021000001814
发表时间: 2002-08-01
影响因子: 4.5
作者:
Ogiso, T;Shiraki, T;Wada, T
通讯作者: Wada, T